These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia. Weisman D; Beinart R; Erez A; Koren-Morag N; Goldenberg I; Eldar M; Glikson M; Luria D J Interv Card Electrophysiol; 2017 Sep; 49(3):255-261. PubMed ID: 28664342 [TBL] [Abstract][Full Text] [Related]
6. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Leaf A; Albert CM; Josephson M; Steinhaus D; Kluger J; Kang JX; Cox B; Zhang H; Schoenfeld D; Circulation; 2005 Nov; 112(18):2762-8. PubMed ID: 16267249 [TBL] [Abstract][Full Text] [Related]
7. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial. Zareba W; Daubert JP; Beck CA; Huang DT; Alexis JD; Brown MW; Pyykkonen K; McNitt S; Oakes D; Feng C; Aktas MK; Ayala-Parades F; Baranchuk A; Dubuc M; Haigney M; Mazur A; McPherson CA; Mitchell LB; Natale A; Piccini JP; Raitt M; Rashtian MY; Schuger C; Winters S; Worley SJ; Ziv O; Moss AJ; J Am Coll Cardiol; 2018 Aug; 72(6):636-645. PubMed ID: 30071993 [TBL] [Abstract][Full Text] [Related]
8. Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials. Khoueiry G; Abi Rafeh N; Sullivan E; Saiful F; Jaffery Z; Kenigsberg DN; Krishnan SC; Khanal S; Bekheit S; Kowalski M Heart Lung; 2013; 42(4):251-6. PubMed ID: 23714269 [TBL] [Abstract][Full Text] [Related]
9. Assessing the impact of omega-3 fatty acids on ventricular tachyarrhythmia and survival in patients with ICDs: A systematic review and meta-analysis. Kohansal E; Askarinejad A; MozafaryBazargany M; Sabahizadeh A; Pakmehr S; Haghjoo M Int J Cardiol Heart Vasc; 2024 Jun; 52():101397. PubMed ID: 38584673 [TBL] [Abstract][Full Text] [Related]
10. Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial. Finzi AA; Latini R; Barlera S; Rossi MG; Ruggeri A; Mezzani A; Favero C; Franzosi MG; Serra D; Lucci D; Bianchini F; Bernasconi R; Maggioni AP; Nicolosi G; Porcu M; Tognoni G; Tavazzi L; Marchioli R Am Heart J; 2011 Feb; 161(2):338-343.e1. PubMed ID: 21315217 [TBL] [Abstract][Full Text] [Related]
11. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245 [TBL] [Abstract][Full Text] [Related]
12. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ; J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671 [TBL] [Abstract][Full Text] [Related]
14. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. Mitchell LB; Powell JL; Gillis AM; Kehl V; Hallstrom AP; J Am Coll Cardiol; 2003 Jul; 42(1):81-7. PubMed ID: 12849664 [TBL] [Abstract][Full Text] [Related]
16. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258 [TBL] [Abstract][Full Text] [Related]
18. Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. Steinberg JS; Beckman K; Greene HL; Marinchak R; Klein RC; Greer SG; Ehlert F; Foster P; Menchavez E; Raitt M; Wathen MS; Morris M; Hallstrom A J Cardiovasc Electrophysiol; 2001 Sep; 12(9):996-1001. PubMed ID: 11573709 [TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820 [TBL] [Abstract][Full Text] [Related]
20. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study. Cappato R Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]